Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma: a randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA (Q33385353)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma: a randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA
scientific article

    Statements

    title
    Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma: a randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19593797
    retrieved
    26 July 2017
    author
    Corinne Haioun
    object named as
    Corinne Haioun
    series ordinal
    3
    0 references
    author name string
    Vincent Ribrag
    series ordinal
    1
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19593797
    retrieved
    26 July 2017
    Christian Gisselbrecht
    series ordinal
    2
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19593797
    retrieved
    26 July 2017
    Gilles Salles
    series ordinal
    4
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19593797
    retrieved
    26 July 2017
    Jean-Baptiste Golfier
    series ordinal
    5
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19593797
    retrieved
    26 July 2017
    Marjan Ertault
    series ordinal
    6
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19593797
    retrieved
    26 July 2017
    Christophe Ferme
    series ordinal
    7
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19593797
    retrieved
    26 July 2017
    Josette Briere
    series ordinal
    8
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19593797
    retrieved
    26 July 2017
    Pauline Brice
    series ordinal
    9
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19593797
    retrieved
    26 July 2017
    Nicolas Mounier
    series ordinal
    10
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19593797
    retrieved
    26 July 2017
    page(s)
    4540-4546
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19593797
    retrieved
    26 July 2017
    cites work

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q33385353&oldid=1624405180"